Volpara signs distribution agreement with Screenpoint Medical

Company News

by Anna Napoli

Medical technology company Volpara (ASX:VHT) has today entered into a full distribution agreement with AI software company ScreenPoint Medical.

The agreement allows Volpara to distribute ScreenPoint’s Transpara™ product to breast imaging clinics in Australia, New Zealand, the United States, and parts of Asia.

Volpara says combining the Volpara and Transpara solutions can optimise the early detection of breast cancer, thereby reducing radiologist liability and risk, and cutting screening costs by potentially eliminating a reader in systems that deploy double-reading mammography.

The deal is a five-year, non-exclusive contract with automatic renewal rights.

Shares in Volpara (ASX:VHT) are trading 3.38 per cent higher at $1.68.

Anna Napoli

Finance News Network
Anna joined FNN February 2018 and also works with Channel 7 as a freelance producer. Anna has also worked as a lawyer and lecturer. She has also presented news updates for interstate news with Southern Cross Austereo.